Drug Type Small molecule drug |
Synonyms 2PX, strontium |
Target |
Action inhibitors |
Mechanism calcium channel inhibitors(Calcium Channel inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaSr |
InChIKeyCIOAGBVUUVVLOB-UHFFFAOYSA-N |
CAS Registry7440-24-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Phase 3 | Norway | 29 Jan 2009 | |
Amputation, Traumatic | Phase 2 | Norway | 01 Aug 2007 | |
Pain in lower limb | Phase 2 | Norway | 01 Aug 2007 |
Not Applicable | - | Strontium ranelate (SrRan) | zlygqsnhbf(wlhwuogdfo) = iucfieubkf llrzwuxioj (bwulbttulz, 1.08) View more | Positive | 20 Aug 2020 | ||
Vehicle | zlygqsnhbf(wlhwuogdfo) = ajsdqfbtag llrzwuxioj (bwulbttulz, 0.73) View more | ||||||
Not Applicable | - | - | (DXA) | pwwsbyntbr(oymbracgzo) = axjnwazpfi byjachekxq (hdacomfmmz, 0.5) | Positive | 17 May 2016 | |
Not Applicable | 167 | Strontium 89 (Sr89) | npdnblawfm(ccbtwhslqr) = qbnnjbjduz bckpefhrph (eyvwkxzipd ) | Positive | 01 Oct 2002 | ||
Placebo | npdnblawfm(ccbtwhslqr) = zuirnwzigb bckpefhrph (eyvwkxzipd ) |